The global over the counter (OTC) drugs market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth in this market is attributed to factors such as increasing demand for OTC drugs due to their convenience and availability, and growing awareness about the benefits of OTC drugs among consumers.
The global over the counter (OTC) drugs market by type is segmented into analgesics, dermatology products, gastrointestinal products, vitamins and minerals supplements (VMS), weight loss/dietary products, ophthalmic products and sleeping aids. The analgesics segment accounted for a share of around 40% in 2017 owing to its wide range of applications such as pain relief from headaches or muscle aches; relief from menstrual cramps; relief from toothaches or earaches; relief from colds or flu symptoms; treatment for arthritis pain; treatment for back pain etc Dermatology products accounted for a share of around 30% in 2017 owing to its wide range of applications such as acne treatments; skin care treatments like moisturizers or sunscreens etc; hair care treatments like dandruff shampoos etc; nail care treatments like nail polish removers etc; foot care treatments like foot creams etc; oral hygiene treatments like mouthwashes etc, which are used by people with sensitive skin types that are prone to allergies or other skin conditions. Gastrointestinal product accounted for a share of around 10% in 2017 owing to its wide range of applications such as antacids that relieve heartburns caused by stomach acidity and indigestion caused by overeating rich foods containing fats and sugars; laxatives that relieve constipation caused due to lack of fiber intake in diet which can lead towards colon cancer if not treated on time with laxatives which help stimulate bowel movements through increased water content in stool thereby easing bowel movement process thereby preventing constipation-related diseases including colon cancer if not treated on time with laxatives which help stimulate bowel movements through increased water content in stool thereby easing bowel movement process thereby preventing constipation-related diseases including colon cancer if not treated on time with laxatives which help stimulate bowel movements through increased water content in stool thereby easing bowel movement process thereby preventing constipation-related diseases including colon cancer if not treated on time with laxatives which help stimulate bowel movements through increased water content in stool thereby easing bowel movement process thereby preventing constipation-related diseases including colon cancer if not treated on time with laxatives which help stimulate bowel movements through increased water content in stool thereby easing bowel movement process thus preventing constipation-related diseases including colon cancer if not treated on time with laxatives). Vitamins & mineral supplements (VMS) accounted for a share of around 10%in 2017 owing primarily because they provide essential nutrients required by body cells but cannot be synthesized internally hence need external sources either via food intake or supplementation form VMS tablets/capsules/pills/drops available at pharmacies without prescription requirement unlike other categories where prescriptions are mandatory before purchase can be made). Weight loss & dietary supplements accounted for a share between 5%-10%. Ophthalmic Products account between 5%-10%. Sleeping Aids account between 5%-10%.
- Factors such as increasing demand for self-medication and rising awareness about the benefits of self-medication are driving the growth of this market globally .
- Increasing prevalence of chronic diseases such as diabetes and hypertension is also driving the growth of this market globally.
- Increasing number of women in workforce has led to increased demand for convenience products.
Industry Growth Insights published a new data on “Over The Counter (OTC) Drugs Market”. The research report is titled “Over The Counter (OTC) Drugs Market research by Types (Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Others), By Applications (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others), By Players/Companies Bayer AG, Boehringer Ingelheim, GlaxoSmithKline PLC, Johnson & Johnson, Novartis International AG, Pfizer,Inc., PGT healthcare, Sanofi S.A, Takeda”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Over The Counter (OTC) Drugs Market Research Report
By Type
Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others
By Companies
Bayer AG, Boehringer Ingelheim, GlaxoSmithKline PLC, Johnson & Johnson, Novartis International AG, Pfizer,Inc., PGT healthcare, Sanofi S.A, Takeda
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
 Drugs Industry Outlook.svg)
Global Over The Counter (OTC) Drugs Market Report Segments:
The global Over The Counter (OTC) Drugs market is segmented on the basis of:
Types
Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer AG
- Boehringer Ingelheim
- GlaxoSmithKline PLC
- Johnson & Johnson
- Novartis International AG
- Pfizer,Inc.
- PGT healthcare
- Sanofi S.A
- Takeda
 Drugs Market Overview.svg)
Highlights of The Over The Counter (OTC) Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Analgesics
- Dermatology Products
- Gastrointestinal Products
- Vitamins, Mineral, and Supplements (VMS)
- Weight Loss/Dietary Products
- Ophthalmic Products
- Sleeping Aids
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Over The Counter (OTC) Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Drugs Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OTC drugs are medications that are not typically prescribed by a doctor, but can be purchased over the counter.
Some of the major companies in the over the counter (otc) drugs market are Bayer AG, Boehringer Ingelheim, GlaxoSmithKline PLC, Johnson & Johnson, Novartis International AG, Pfizer,Inc., PGT healthcare, Sanofi S.A, Takeda.
The over the counter (otc) drugs market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Over The Counter (OTC) Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Over The Counter (OTC) Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Over The Counter (OTC) Drugs Market - Supply Chain
4.5. Global Over The Counter (OTC) Drugs Market Forecast
4.5.1. Over The Counter (OTC) Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Over The Counter (OTC) Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Over The Counter (OTC) Drugs Market Absolute $ Opportunity
5. Global Over The Counter (OTC) Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Over The Counter (OTC) Drugs Market Size and Volume Forecast by Type
5.3.1. Analgesics
5.3.2. Dermatology Products
5.3.3. Gastrointestinal Products
5.3.4. Vitamins, Mineral, and Supplements (VMS)
5.3.5. Weight Loss/Dietary Products
5.3.6. Ophthalmic Products
5.3.7. Sleeping Aids
5.3.8. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Over The Counter (OTC) Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Over The Counter (OTC) Drugs Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacy
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Over The Counter (OTC) Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Over The Counter (OTC) Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Over The Counter (OTC) Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Over The Counter (OTC) Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Over The Counter (OTC) Drugs Demand Share Forecast, 2019-2026
9. North America Over The Counter (OTC) Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Over The Counter (OTC) Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Over The Counter (OTC) Drugs Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacy
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Over The Counter (OTC) Drugs Market Size and Volume Forecast by Type
9.7.1. Analgesics
9.7.2. Dermatology Products
9.7.3. Gastrointestinal Products
9.7.4. Vitamins, Mineral, and Supplements (VMS)
9.7.5. Weight Loss/Dietary Products
9.7.6. Ophthalmic Products
9.7.7. Sleeping Aids
9.7.8. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Over The Counter (OTC) Drugs Demand Share Forecast, 2019-2026
10. Latin America Over The Counter (OTC) Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Over The Counter (OTC) Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Over The Counter (OTC) Drugs Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacy
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Over The Counter (OTC) Drugs Market Size and Volume Forecast by Type
10.7.1. Analgesics
10.7.2. Dermatology Products
10.7.3. Gastrointestinal Products
10.7.4. Vitamins, Mineral, and Supplements (VMS)
10.7.5. Weight Loss/Dietary Products
10.7.6. Ophthalmic Products
10.7.7. Sleeping Aids
10.7.8. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Over The Counter (OTC) Drugs Demand Share Forecast, 2019-2026
11. Europe Over The Counter (OTC) Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Over The Counter (OTC) Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Over The Counter (OTC) Drugs Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacy
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Over The Counter (OTC) Drugs Market Size and Volume Forecast by Type
11.7.1. Analgesics
11.7.2. Dermatology Products
11.7.3. Gastrointestinal Products
11.7.4. Vitamins, Mineral, and Supplements (VMS)
11.7.5. Weight Loss/Dietary Products
11.7.6. Ophthalmic Products
11.7.7. Sleeping Aids
11.7.8. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Over The Counter (OTC) Drugs Demand Share, 2019-2026
12. Asia Pacific Over The Counter (OTC) Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Over The Counter (OTC) Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Over The Counter (OTC) Drugs Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacy
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Over The Counter (OTC) Drugs Market Size and Volume Forecast by Type
12.7.1. Analgesics
12.7.2. Dermatology Products
12.7.3. Gastrointestinal Products
12.7.4. Vitamins, Mineral, and Supplements (VMS)
12.7.5. Weight Loss/Dietary Products
12.7.6. Ophthalmic Products
12.7.7. Sleeping Aids
12.7.8. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Over The Counter (OTC) Drugs Demand Share, 2019-2026
13. Middle East & Africa Over The Counter (OTC) Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Over The Counter (OTC) Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Over The Counter (OTC) Drugs Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacy
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Over The Counter (OTC) Drugs Market Size and Volume Forecast by Type
13.7.1. Analgesics
13.7.2. Dermatology Products
13.7.3. Gastrointestinal Products
13.7.4. Vitamins, Mineral, and Supplements (VMS)
13.7.5. Weight Loss/Dietary Products
13.7.6. Ophthalmic Products
13.7.7. Sleeping Aids
13.7.8. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Over The Counter (OTC) Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Over The Counter (OTC) Drugs Market: Market Share Analysis
14.2. Over The Counter (OTC) Drugs Distributors and Customers
14.3. Over The Counter (OTC) Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boehringer Ingelheim
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline PLC
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson & Johnson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis International AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer,Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. PGT healthcare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sanofi S.A
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Takeda
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19.&n
